Biopharmaceutical research companies are conducting or have conducted nearly 5,000 clinical trials of new medicines in collaboration with the state’s clinical research centers, university medical schools and hospitals (1999 to present).
Of the nearly 5,000 clinical trials, 2,494 target or have targeted the nation’s six most debilitating chronic diseases—asthma, cancer, diabetes, heart disease, mental illnesses and stroke.
Biopharmaceutical companies’ close collaboration with clinicians and research institutions in Ohio benefits patients, the state’s economy, and the advancement of sci- ence and patient care. Clinical trial work is good business for the state’s medical schools and clinical research centers and the medicines being tested are often cutting-edge cell and protein treatments with the potential to be safer and more effective than older chemical compound drugs. What’s more, Ohioans contemplating participation in clinical trials, in consultation with their doctors, have a wide range of choices—nearly 500 tests of new medicines for the six most debilitating chronic diseases in America are underway in communities large and small all over the state and they need patient volunteers.